Variant CJD and blood transfusion: Are there additional cases?

Vox Sanguinis

Volumn 107, Issue 3, 2014, Pages 220-225

  Davidson, L R R ^a   Llewelyn, C A ^b   Mackenzie, J M ^a   Hewitt, P E ^b   Will, R G ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

^b NHS BLOOD AND TRANSPLANT   (United Kingdom)

Author keywords

Blood; Transfusion; Variant Creutzfeldt Jakob disease

Indexed keywords

PENTOSAN POLYSULFATE;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOPSY; BLOOD DONOR; BLOOD TRANSFUSION; BRAIN SCINTISCANNING; CLINICAL ARTICLE; DEMOGRAPHY; FEMALE; HOSPITAL; HUMAN; MALE; MEDICAL RECORD; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PHENOTYPE; PRIORITY JOURNAL; RECIPIENT; REGISTER; VARIANT CREUTZFELDT JAKOB DISEASE; ADVERSE EFFECTS; BLOOD; CREUTZFELDT-JAKOB SYNDROME; MIDDLE AGED; TRANSMISSION; UNITED KINGDOM; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BLOOD DONORS; BLOOD TRANSFUSION; CREUTZFELDT-JAKOB SYNDROME; FEMALE; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84925305799     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/vox.12161     Document Type: Article

References (14)

1. Will RG, Ironside JW, Zeidler M, et al.: A new variant of Creutzfeldt-Jakob Disease in the United Kingdom. Lancet 1996; 347:921-925
2. Bruce ME, Will RG, Ironside JW, et al.: Transmission to mice indicates the new variant CJD is caused by the BSE agent. Nature 1997; 289:498-501
3. National CJD Research and Surveillance Unit website: http://www.cjd.ed.ac.uk/documents/figs.pdf
4. Hilton DA, Ghani AC, Conyors L, et al.: Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J Pathol 2004; 203:733-739
5. Gill ON, Spencer Y, Richard-Loendt A, et al.: Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic: large scale survey. BMJ 2013; 347:f5675
6. Bruce ME, McConnell I, Will RG, et al.: Detection of variant Creutzfeldt-Jakob disease infectivity in extraneural tissues. Lancet 2001; 358:208-209
7. Head MW, Ritchie D, Smith N, et al.: Peripheral tissue involvement in sporadic, iatrogenic and variant Creutzfeldt-Jakob disease: an immunohistochemical, quantative, and biochemical study. Am J Pathol 2004; 164:143-153
8. Hewitt PE, Llewelyn CA, Mackenzie J, et al.: Creutzfeldt-Jakob disease and blood transfusion: results of the UK transfusion medicine epidemiological review study. Vox Sang 2006; 91:221-230
9. Peden AH, Head M, Ritchie DL, et al.: Preclinical variant Creutzfeldt-Jakob disease after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 2004; 364:527-529
10. Bishop MT, Diack AB, Ritchie DL, et al.: Prion infectivity in the spleen of a PRNP heterozygous individual with subclinical variant Creutzfeldt-Jakob disease. Brain 2013; 136(Pt 4):1139-1145
11. Turner ML, Ludlam CA: An update on the assessment and management of the risk of transmission of variant Creutzfeldt-Jakob disease by blood and plasma products. Br J Haematol 2009; 144:14-23
12. Bishop MT, Ritchie DL, Will RG, et al.: No major change in variant Creutzfeldt-Jakob disease agent strain after secondary transmission via blood transfusion. PLoS ONE 2008; 3:1-6
13. Chohan G, Llewelyn C, Mackenzie J, et al.: Variant Creutzfeldt-Jakob disease in a transfusion recipient: coincidence or cause? Transfusion 2010; 50:1003-1006
14. Newman PK, Todd NV, Scoones D, et al.: Portmortem findings in a case of variant Creutzfeldt-Jakob disease treated with intraventricular pentosan polysulfate. J Neurol Neurosurg Psychiatry 2014; 85:921-924